$PRXL (PAREXEL International Corporation)

$PRXL {{ '2016-06-10T13:14:55+0000' | timeago}} • Announcement

Biopharmaceutical services provider $PRXL said it has signed a master services agreement with $PFE. Under the terms of this agreement, the company will continue to provide global clinical R&D services to $PFE in support of clinical development programs across its portfolio. Terms of the agreement were not disclosed.

$IBM {{ '2017-07-21T17:53:42+0000' | timeago}} • Announcement

$IBM and University of Alberta published new data in Nature's partner journal Schizophrenia, exhibiting that machine learning algorithms helped predict schizophrenia with 74% accuracy. The technology predicted the severity of some symptoms in schizophrenia patients with significant correlation.

$MCK {{ '2017-07-21T16:07:44+0000' | timeago}} • Announcement

Biologics, a unit of healthcare technology firm $MCK, said it will join the limited distribution network of $PBYI to promote the latter’s kinase inhibitor Nerlynx. The formulation is indicated for treatment of adult patients with early-stage HER2 overexpressed/amplified breast cancer.

$MRK {{ '2017-07-21T15:21:07+0000' | timeago}} • Announcement

President Donald Trump announced that pharma giants $MRK and $PFE are collaborating with Gorilla Glass manufacturer Corning ($GLW) for manufacturing a new glass (Valor Glass), which is superior and reliable for the delivery of injectable drugs. Corning is planning to initially invest $500MM creating 1,000 jobs at 3 facilities in US.

$MSFT {{ '2017-07-21T12:34:48+0000' | timeago}} • Announcement

$MSFT's Intelligent Cloud unit revenue grew 11% in 4Q17, boosted by growth in server products and cloud services. Revenue of server products and cloud services was up 15%, while Azure, the software giant's cloud platform, surged 97%. Last week, $MSFT announced that $DNB and Chinese Internet firm $BIDU will use Azure for their cloud computing needs.

$NLSN {{ '2017-07-20T18:54:03+0000' | timeago}} • Announcement

$NLSN declared a quarterly cash dividend of $0.34 per share of common stock. The dividend is payable on September 7, 2017 to stockholders of record at the close of business on August 24, 2017.

$MRK {{ '2017-07-20T14:29:27+0000' | timeago}} • Announcement

$MRK announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval for its 100 units/mL insulin glargine injection, a follow-on biologic basal insulin in a pre-filled dosing device.

$INCY {{ '2017-07-20T13:24:37+0000' | timeago}} • Announcement

$INCY said first patient has been treated in Phase 3 trial of itacitinib for the first-line treatment of patients with acute graft-versus-host disease (GVHD). GVHD is a condition that might occur after an allogeneic transplant, whereby the donated bone marrow or peripheral blood stem cells view the recipient’s body as foreign and attack the body.

$MSFT {{ '2017-07-19T21:56:12+0000' | timeago}} • Announcement

$MSFT and $DNB announces a strategic partnership. $DNB will use Microsoft Azure as its cloud platform. Dun & Bradstreet data will be made available through Microsoft Dynamics 365, a cloud-powered service, and the Microsoft’s Common Data Service. Also, the tech giant and D&B will enter into a co-selling arrangement beginning later this year.

$IBM {{ '2017-07-19T19:00:41+0000' | timeago}} • Webcast

$IBM expects improved revenue and gross margin performance in 2H17, pushed by its new IBM z systems mainframe servers launch in 2Q17. However, the company expects most of the growth to happen in 4Q17.

$AGN {{ '2017-07-19T15:54:53+0000' | timeago}} • Announcement

$AGN appointed Joseph Boccuzi to its BoD, effective immediately. Boccuzi recently retired as a Partner in the Global Life Sciences, Board and Chief Executive Officer Practices at Spencer Stuart, following 24 years of service with the global executive search and leadership consulting firm.

$DNB {{ '2017-07-19T14:40:03+0000' | timeago}} • Announcement

$DNB said it is teaming up with $MSFT to give companies worldwide direct access to its data through $MSFT's cloud services. $DNB has selected $MSFT as a strategic cloud provider to accelerate the company's digital transformation and deliver its customers more efficient and seamless access to its commercial data.

$IBM {{ '2017-07-18T23:42:39+0000' | timeago}} • Announcement

$IBM maintained its FY17 EPS and cash flow expectations. The company continues to expect adjusted diluted EPS of at least $13.80 and GAAP diluted EPS of at least $11.95. Free cash flow is expected to be relatively flat year-to-year.

$IBM {{ '2017-07-18T23:35:37+0000' | timeago}} • Announcement

Big Blue $IBM reported 21st consecutive quarter of revenue decline, with 2Q17 earnings declining 7%. The decline was driven by all segments reporting a decline in revenue YoY. Net income was $2.3Bil or $2.48 per share in 2Q17, down from $2.5Bil or $2.61 per share a year ago. Revenue declined 4.7% to $19.3Bil.

$IBM {{ '2017-07-18T21:07:52+0000' | timeago}} • Infographic

$IBM International Business Machines Earnings AlphaGraphic: Q2 2017 Highlights

$LH {{ '2017-07-18T13:30:08+0000' | timeago}} • Announcement

Insurance company $LH said its CEO William Hanlon has been appointed as a member of the governing committee of the National Evaluation System for Health Technology Coordinating Center. Hanlon has been focused on early and late-stage clinical development, as a regulatory affairs expert, for the past several years.

$VRX {{ '2017-07-17T14:04:54+0000' | timeago}} • Announcement

$VRX has entered into an agreement to sell its Obagi Medical Products business for $190MM in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P. The transaction is expected to close in second half of 2017. $VRX intends to use the proceeds from the sale to permanently repay term loan debt under its Senior Secured Credit Facility.

$VRTX {{ '2017-07-13T12:31:35+0000' | timeago}} • Announcement

$VRTX announced that the Italian Medicines Agency has agreed to reimburse ORKAMBI (lumacaftor/ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis in people ages 12 and older who have two copies of the F508del mutation. Effective immediately, hundreds of eligible patients in Italy will have access to this medicine.

$AMGN {{ '2017-07-13T12:24:26+0000' | timeago}} • Announcement

$AMGN and $AGN announced they will discuss data supporting the ABP 215 Biologics License Application (BLA) with FDA's Oncologic Drugs Advisory Committee. ABP 215 is a biosimilar candidate to Avastin (bevacizumab) and is the first bevacizumab biosimilar candidate to be considered by the FDA.

$IBM {{ '2017-07-12T13:39:37+0000' | timeago}} • Announcement

$IBM announced the first IBM Watson-based services platform fully built on the IBM Cloud that augments human intelligence to help improve service provider operations via cognitive technologies and freeing up professionals to focus on driving higher value results.

$NLSN {{ '2017-07-11T20:04:31+0000' | timeago}} • Announcement

$NLSN said podcasting company Panoply Media has selected the Nielsen Data Management Platform to power in part its Megaphone Targeted Marketplace. $NLSN will provide Panoply with consumer insights and audience segmentation, enabling its advertising partners to tailor their messages to specific podcast audiences and increase campaign performance.

Recent Transcripts

SRPT (Sarepta Therapeutics, Inc.)
Wednesday, July 19 2017 - 8:30pm
IBM (International Business Machines Corporation)
Tuesday, July 18 2017 - 9:00pm
INFY (Infosys Limited)
Friday, July 14 2017 - 12:30pm
INFY (Infosys Limited)
Friday, July 14 2017 - 6:00am
MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
XON (Intrexon Corporation)
Wednesday, May 10 2017 - 8:30pm
CRL (Charles River Laboratories International, Inc.)
Wednesday, May 10 2017 - 12:30pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
AGN (Allergan plc)
Tuesday, May 9 2017 - 12:30pm
VRX (Valeant Pharmaceuticals International, Inc.)
Tuesday, May 9 2017 - 12:00pm
CTSH (Cognizant Technology Solutions Corporation)
Friday, May 5 2017 - 12:00pm
INCY (Incyte Corporation)
Thursday, May 4 2017 - 2:00pm
PRXL (PAREXEL International Corporation)
Thursday, May 4 2017 - 2:00pm
Q (Quintiles Transnational Holdings Inc.)
Wednesday, May 3 2017 - 1:00pm
DNB (Dun & Bradstreet Corp.)
Tuesday, May 2 2017 - 12:00pm
MRK (Merck & Co. Inc.)
Tuesday, May 2 2017 - 12:00pm
EXEL (Exelixis, Inc.)
Monday, May 1 2017 - 9:00pm
SNMX (Senomyx Inc.)
Thursday, April 27 2017 - 9:00pm
SRPT (Sarepta Therapeutics, Inc.)
Thursday, April 27 2017 - 8:30pm
VRTX (Vertex Pharmaceuticals Incorporated)
Thursday, April 27 2017 - 8:30pm

AlphaGraphics you may like